PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary embolism |
| Phenotype | C0149782|squamous cell lung cancer |
| Sentences | 1 |
| PubMedID- 22076388 | Bevacizumab, the monoclonal antibody to vascular endothelial growth factor (vegf), has been associated with hemoptysis and pulmonary embolism particularly in patients with squamous cell lung cancer. |
Page: 1